Liquid Biopsy Market Research Reports 2018-2023

Posted August 29, 2018 by sandycool

Liquid Biopsy market is expected to increase at a CAGR of 24.3% in the forecast period of 2018-2023 and reach a value of USD 3722.94 million by 2023 from USD 1166.72 million in 2018.
Liquid Biopsy Market values at USD 1166.72 Million in 2018 and it is expected to reach USD 3722.94 Millions with a CAGR of 24.3% by the end of 2023. While tissue biopsies are standard for cancer diagnosis for past many years, their extremely invasive nature and often associated complications are major concerns. Moreover, these biopsies result in high expenditure being incurred by patients. Liquid biopsies, on the other hand, offer a less invasive methodology along with high effectiveness. Thus, there are a number of key personal organizations concerned in rigorous R&D activities for liquid biopsy, diagnostic assay, test development and it's only a matter of time before these procedures grow in prominence in diagnostic equipment of oncologists and pathologists.

Request Report Sample:

Factors affecting market growth:
• Increasing prevalence of cancer(+)
• Increasing preference for noninvasive procedures(+)
• Initiatives taken by government and global health organizations (+)
• These is replacing tissue diagnosis procedures
• High expenditure restraint the growth of the market (-)

Get your customized report:

Market Segmentation
Global Liquid Biopsy market is segmented on the basis of

Cancer type
• Lung Cancer
• Pancreatic Cancer
• Leukemia cancer
• Other Visceral Cancers
Sample Type
• Blood
• Urine
• Plasma
• Saliva
• Cerebrospinal
Diagnostic Approach
• Circulating Tumor Cells
• Circulating Tumor DNA
• RNA in Exosomes
• Extra cellular Vesicles
End Users
• Reference Laboratories
• Hospitals
• Academic and Research centers
• Other End user

Based on circulating Biomarker, the circulating tumor cells segment expected to account the largest share of liquid biopsy market. On the basis of application Therapy selection is accounted for the largest share because it has ability of therapy selection t detect advanced stage cancers.

Browse full Table of Contents:

Key players:
The major companies dominating the global Liquid Biopsy Market are Janssen Diagnostics, Qiagen, Rarecells SAS, Silicon Biosystems, SRI International, Myriad Genetics, Natera, Personal Genome Diagnostics, Sysmex Inostics, Trovagene, Exosome Diagnostics, Exosome Sciences, and HansaBiomed OU.

Contact Info:
Name: Mr. Abhishek Shukla
Email: [email protected]
Organization: MarketDataForecast™
Address: 2nd Floor, Above ICICI Bank,B-44, Rd Number 3, Journalist Colony, Film Nagar, Hyderabad, Telangana 500033, India.
Phone: +1-888-702-9626
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By Market Data Forecast
Phone 18887029626
Business Address Hyderabad
Country India
Categories Advertising , Agriculture
Tags marketanalysis , marketprice , marketshare
Last Updated August 29, 2018